X4 PHARMACEUTICALS INC has a total of 70 patent applications. It decreased the IP activity by 44.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are EUCLISES PHARMACEUTICALS INC, GLYTHERA LTD and SRX CARDIO LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 14 | |
#3 | Canada | 13 | |
#4 | EPO (European Patent Office) | 13 | |
#5 | China | 12 | |
#6 | Australia | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Skerlj Renato | 23 |
#2 | Bourque Elyse Marie Josee | 23 |
#3 | Ragan Paula Marie | 21 |
#4 | Arbeit Robert D | 20 |
#5 | Wang Yan | 14 |
#6 | Sprott Kam Marie | 8 |
#7 | Arbeit Robert M | 6 |
#8 | Brands Karel Marie Joseph | 6 |
#9 | Mcdermott David | 5 |
#10 | Fricker Simon Paul | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020264292A1 | Cxcr4 inhibitors and uses thereof | |
CN112005114A | Cancer serum biomarkers and methods of use thereof | |
US2021009557A1 | Acyclic cxcr4 inhibitors and uses thereof | |
US10548889B1 | Compositions of CXCR4 inhibitors and methods of preparation and use | |
EP3707158A1 | Cancer biomarkers and methods of use thereof | |
CN110996952A | Methods for treating cancer | |
CN109641838A | CXCR4 inhibitor and application thereof | |
US2020255414A1 | CXCR4 inhibitors and uses thereof | |
EP3808748A1 | Substituted piperidines as cxcr4-inhibitors | |
US2019160051A1 | Methods for treating cancer | |
WO2017127811A1 | Methods for treating cancer | |
US2019083485A1 | Methods for treating immunodeficiency disease | |
US2018369167A1 | Methods for treating cancer | |
EP3389634A1 | Methods for treating cancer |